Lipopolysaccharides protect mesenchymal stem cell against cardiac ischemia-reperfusion injury by HMGB1/STAT3 signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lipopolysaccharides protect mesenchymal stem cell against cardiac ischemia-reperfusion injury by HMGB1/STAT3 signaling

Published:2023-11 Issue:11 Volume:20 Page:801-812
ISSN:1671-5411
Container-title:Journal of Geriatric Cardiology
language:en
Short-container-title:

Author:

WEN Jing-Yi,PENG Hui-Xi,WANG Dan,WEN Zhi-Min,LIU Yu-Tong,QU Jian,CUI Hong-Xuan,WANG Yu-Ying,DU Yan-Lin,WANG Ting,GENG Cong,XU Bing

Publisher

Tsinghua University Press

Reference38 articles.

1. Heart disease and stroke statistics-2019 update: a report from the American Heart Association;EJ Benjamin;Circulation,2019

2. Timely and optimal treatment of patients with STEMI;JF Lassen;Nat Rev Cardiol,2013

3. Myocardial ischemia-reperfusion injury: a neglected therapeutic target;DJ Hausenloy;J Clin Invest,2013

4. Cell death;RS Hotchkiss;N Engl J Med,2009

5. Therapeutic strategies in ischemic cardiomyopathy: Focus on mitochondrial quality surveillance;X Chang;EBioMedicine,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SHARPIN contributes to sevoflurane-induced neonatal neurotoxicity through up-regulating HMGB1 to repress M2 like-macrophage polarization;Metabolic Brain Disease;2024-05-28

2. Dexmedetomidine alleviates Hypoxia/reoxygenation-induced mitochondrial dysfunction in cardiomyocytes via activation of Sirt3/Prdx3 pathway;DARU Journal of Pharmaceutical Sciences;2024-02-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP